Legend Biotech Corporation Announces Proposed Public Offering
Legend Biotech announced a proposed underwritten public offering of $225 million of American Depositary Shares, with underwriters granted a 30-day option to purchase up to an additional 15% of shares sold. Morgan Stanley, Jefferies, Citigroup, and Deutsche Bank Securities are acting as joint book-running managers for the offering.
Key figures
- Deal Value Usd
- 225000000
- Greenshoe option
- 15%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.